Chervil (Anthriscus cerefolium): A Comprehensive Reference
1. Identity and Botanical Description
Chervil (Anthriscus cerefolium), sometimes called French parsley or garden chervil (to distinguish it from similar plants also called chervil), is a delicate annual herb related to parsley. It is a common plant genus of the family Apiaceae. It was formerly called myrhis due to its volatile oil with an aroma similar to the resinous substance myrrh.
The name chervil is from Anglo-Norman, from Latin chaerephylla or choerephyllum, meaning "leaves of joy"; the Latin is formed from an Ancient Greek word χαιρέφυλλον (chairephyllon). The species name cerefolium appears to mean "leaves like wax" and might refer to the bright green colour, but is more possibly a spelling mistake for cherifolium (Greek chairephyllon), the name the Romans used for this plant (Greek chairein to delight in and phyllon leaf, referring to the pleasant aroma of the leaves).
Morphology
The plants grow to 40–70 cm (16–28 in), with tripinnate leaves that may be curly. The small white flowers form small umbels, 2.5–5 cm (1–2 in) across. The fruit is about 1 cm long, oblong-ovoid with a slender, ridged beak.
Taxonomy and Related Species
Both chervil and parsley belong to the carrot family, Apiaceae, but chervil is a member of the genus Anthriscus, while parsley is a member of the genus Petroselinum. The genus comprises 12 species, some of which are considered as noxious weeds. Chervil should not be confused with wild chervil (Anthriscus sylvestris), also known as cow parsley, which is a distinct species commonly found along roadsides and in meadows and is classified as a weed in many jurisdictions.
There are two main horticultural varieties of garden chervil — plain-leafed and curly-leafed — along with related types including root chervil (Chaerophyllum bulbosum), cultivated for its parsnip-like taproot. Of all these varieties, garden chervil is most commonly used.
Geographic Origin and Distribution
Chervil is native to the Caucasus but was spread to most of Europe by the Romans, as well as to temperate parts of Asia. Chervil is native to Europe and was cultivated first in England in 1597 and in America by 1806. The origin of salad chervil is the region of southeastern Europe and western Asia. Chervil became known in the regions north of the Mediterranean by the edict of Charlemagne, Capitulare de villis.
2. Common Forms and Preparations
Leaves of the chervil are nearly always used fresh, but can be preserved by deep freezing or by making a pesto-like preparation. It may also be used as a dried herb, which is less aromatic, but a useful constituent of various herbal preparations.
It is commonly used to season mild-flavoured dishes and is a constituent of the French herb mixture fines herbes. Chervil is a popular ingredient in French cuisine and one of the four traditional French fines herbes, along with chives, tarragon, and parsley.
The leaves generally have the greatest use and can be eaten fresh or dried. Leaves and roots are steeped to make herbal tea, and a decoction form from its flowers, mixed into a poultice, is said to relieve joint pain and inflammation.
In medicinal and supplementary contexts, chervil preparations include:
- Infusions (herbal teas): Fresh or dried leaves steeped in hot water, used traditionally as a digestive aid or diuretic tonic.
- Poultices: Bruised leaves are used as a poultice for slow-healing wounds. Warm poultice is applied to painful joints.
- Eyewash: An infusion of the fresh leaves is used as eyewash to treat sore or inflamed eyes.
- Methanolic and aqueous extracts: Used in laboratory research, prepared from lyophilized aerial parts of the plant.
- Essential oil: Obtained by water distillation of the herb or seeds, used in aromatic and analytical studies.
- Fresh culinary herb: When cooking with fresh chervil, it is recommended to add the herb to recipes at the last minute as a garnish, since its flavor tends to be lost when it cooks too much.
3. Traditional and Historical Use
Ancient Greece and Rome
The plant has been utilized as a medicinal plant by humankind for millennia and is mentioned in the encyclopedia Historia naturalis by Pliny the Elder (23–79 AD) as an ingredient in vinegar recommended against hiccup. The ancient Greeks used chervil to create healing spring tonics and herbalists used it to cure digestive problems.
Early Modern European Herbalism
Pliny the Elder and Nicolas Culpeper, a 17th-century herbalist, believed that, as Culpeper put it, "[it] does much to please and warm old and cold stomach." During the Middle Ages, chervil was used to treat eye inflammations, smooth skin wrinkles, combat the plague, and treat blood clots.
John Parkinson (1567–1650), a British botanist and herbalist, recommended that the green seeds be added to herb salads dressed with oil and vinegar "to comfort the cold stomach of the aged." In the same period, John Gerard (1545–1612), a botanist and herbalist, wrote that the roots, "first boiled; which is very good for old people that are dull and without courage: it rejoiceth and comforteth the heart, and increaseth their lust and strength." Chervil seems to have been an herb used for the elderly, as both a tonic and to boost brain health.
This species is also mentioned by the seventeenth-century Danish pioneer scientist Simon Paulli (1648) who reports on its use against gallstones.
Spring Tonics and Seasonal Use
The tender young leaves of chervil have been used in spring tonics for thousands of years, dating back to the ancient Greeks. A combination of chervil, dandelion, and watercress was used to rejuvenate the body from vitamin and mineral deficiencies brought on by winter and lack of fresh greens. Even today European herbalists recommend this tonic.
Cultural and Religious Significance
Its flavor and fragrance resemble the myrrh brought by the Wise Men to the baby Jesus. Because of this and because chervil symbolized new life, it is linked to the Easter celebration in parts of Europe where it is traditional to serve chervil soup on Holy Thursday.
Breadth of Traditional Claims
Chervil has been used in the past as a diuretic, expectorant, digestive aid, and skin freshener. It was also thought to relieve symptoms of eczema, gout, kidney stones, and pleurisy. Chervil is a traditional remedy for bad dreams, burns, and stomach problems and supposedly the whole plant alleviates hiccups. It is used as an eyewash for rinsing and refreshing the eyes.
It is important to note that of these properties, the most persistently recognized to this day has been the ability to lower blood pressure, but no clinical studies support this or any of the claims.
4. Key Constituents and Active Compounds
Essential Oil
The plant contains only a small amount of essential oil (0.3% in the fresh herb, 0.9% in the seeds), with methyl chavicol (estragole) as the main constituent. Essential oil obtained via water distillation of wild Turkish Anthriscus cerefolium was analyzed by gas chromatography–mass spectrometry, identifying four compounds: methyl chavicol (83.10%), 1-allyl-2,4-dimethoxybenzene (15.15%), undecane (1.75%), and β-pinene (<0.01%).
The leaves contain about 0.4% (v/w DM) essential oil, where estragole (= methylchavicol) and 1-allyl-2,4-dimethoxybenzene are the main constituents.
Phenolic Compounds and Flavonoids
This species is a highly enriched source of phenolics, containing 1260 mg gallic acid equivalents (GAE) 100–1 g DM; however, the individual phenolic compounds have been scarcely characterized.
The structure of the main phenolic compound was elucidated to be the previously undescribed compound 1,3-dicaffeoyl-5-malonyl-δ-quinide by means of 1D- and 2D NMR and high-resolution mass spectrometry. The known flavones apigenin 7-O-β-(2″-apiofuranosylglucopyranoside) (= apiin), apigenin 7-(2″-apiosyl-6″-malonylglucoside), and luteolin 7-glucoside were also identified.
The previously reported flavones are all derivatives of apigenin and luteolin, including apiin (apigenin 7-apiosylglucoside), luteolin 7-glucoside, and luteolin 7-apiosylglucoside, whereas the identified flavonols are kaempferol, quercetin, and isorhamnetin derivatives.
Coumarins
The active constituents of chervil are volatile oil, flavonoids, and coumarins; other constituents present are methyl chavicol (estragole) and hendecane (undecane). Coumarins identified in related Anthriscus species include scopoletin, isoscopoletin, and bergapten (5-methoxypsoralen). Fruits of Anthriscus cerefolium were among the Apiaceae species analyzed for photoactive furocoumarins, placing chervil within the broader group of Apiaceae plants known to contain these compounds.
Lignans
Different extraction and purification methods have been used to separate essential oil and flavonoids from the leaves and lignans from the root. In the closely related wild chervil (Anthriscus sylvestris), pharmacological importance stems from containing diverse bioactive lignans, especially aryltetralins and dibenzylbutyrolactones. One of the main compounds of A. sylvestris, deoxypodophyllotoxin, among its wide-ranging effects, including antitumor, antiproliferative, antiplatelet aggregation, antiviral, anti-inflammatory, and insecticidal properties, serves as a pivotal precursor to epipodophyllotoxin, crucial in the semisynthesis of cytostatic agents like etoposide and teniposide.
Nutritional Constituents
Fresh chervil provides modest amounts of vitamin C, vitamin A precursors (carotenoids), folate, and vitamin K, along with trace minerals such as iron, calcium, and magnesium. In addition, this herb contains some vitamin C, folate, magnesium, phosphorus, zinc, and selenium. About 100 g of dried chervil offers a significant amount of dietary fiber (around 11.3 g), which assists in keeping the digestive system healthy.
Phytosterols
The herb has been suggested as a good source for phytosterols and new aroma constituents, which may be useful in human nutrition.
5. Scientific Evidence by Area of Use
The PubMed database contains fewer than ten studies on the health effects of Anthriscus cerefolium. These do not include clinical studies, meta-analyses, or (systematic) reviews, but mainly in vitro studies. These are general basic studies — not carried out on humans, but on cell lines in a test tube. The overall body of evidence for chervil as a therapeutic agent is therefore at an early, preclinical stage. No completed human clinical trials of A. cerefolium as a defined intervention have been identified in the peer-reviewed literature.
5.1 Antioxidant Activity
Evidence level: Preclinical (in vitro only)
Characteristic constituents of chervil (Anthriscus cerefolium) were investigated for free radical scavenging effects. Different extraction and purification methods were used to separate essential oil and flavonoids from the leaves, and lignans from the root. In vitro test methods were used to determine whether the extracts had free radical scavenging and membrane protective activity. The identification of the chemical constituents was conducted by HPLC and GC techniques. The following was concluded: flavonoids from the herb and lignans from the root showed strong free radical quenching activity, while the volatile oil obtained from the herb was less effective.
Methanol extracts of Anthriscus cerefolium have a high antioxidant capacity, comparable to that of parsley. This property is due to the phenol content. Both species have the same main flavones, apiin and apigenin, but the most important phenolic component of Anthriscus cerefolium is a novel bicyclic lactone.
These findings are laboratory-based and do not demonstrate antioxidant effects in living humans at food-level exposures. No human trials have assessed the antioxidant effects of chervil intake.
5.2 Antimicrobial Activity
Evidence level: Preclinical (in vitro cell culture)
Since the plant was traditionally used for the treatment of pneumonia, suggesting its antimicrobial effect, one research group tested the activities of extract against microbes Staphylococcus aureus and Candida species.
Decreased rate of proliferation and changes in cell morphology were detected upon treatment of A172 cells with the extract. The antimicrobial activity of the extract was tested against Staphylococcus aureus and Candida species. The extract was active against the tested bacterium and yeasts, inhibiting free-floating cells and microbial biofilms.
A 2024 ScienceDirect study examined A. cerefolium methanolic extract more broadly: Chemical characterization of the extracts was performed by LC–HRMS/MS analysis. Antimicrobial activities of the extract were investigated on six bacteria and eight fungi, while antioxidant activity was assessed by six different assays. The results showed that the obtained extract was rich in phenolic compounds (a total of seventy-two were identified), with malonyl-1,4-O-dicaffeoylquinic acid and 3,5-O-dicaffeoylquinic acid dominating in the sample. The extract expressed antimicrobial, antioxidant, anti-enzymatic, cytotoxic, and anti-inflammatory properties.
The observed antimicrobial activity of extracts of chervil may be assigned to the content of relatively volatile compounds including the known antibiotic compound carvacrol. Studies of biological activity of pure compounds isolated from chervil are, however, lacking in current literature.
5.3 Anticancer and Cytotoxic Activity
Evidence level: Preclinical (in vitro cell lines only)
The main phenolic compound, 1,3-dicaffeoyl-5-malonyl-δ-quinide, exhibited moderate cytotoxicity towards acute monocytic leukaemia cells (MOLM-13) and rat kidney epithelial cells (NRK) with EC50 between 400 and 600 µM.
The 2021 study by Stojković et al. in Pharmaceuticals investigated anti-glioblastoma activity: As traditional uses of the plant include its use against bad dreams, meaning that it probably contains compounds that can pass the blood-brain barrier, the researchers investigated anti-glioblastoma activity of methanolic extract of A. cerefolium. On the day of treatment, fresh medium with different concentrations of the extract (250–1000 µg/mL) dissolved in DMSO was added to the cells and cells were incubated with the extract for 48 hours. The cytotoxic effects of the extract on A172 cells were compared to the same effect on primary human gingival fibroblast (HGF-1) cells. Decreased rate of proliferation and changes in cell morphology were detected upon treatment of A172 cells with the extract. This study is the first one to provide a detailed description of the chemical profile of A. cerefolium extract dealing with scientific insights into its anti-glioblastoma and antimicrobial activities.
Cytotoxic properties of the extract were tested on human immortalized keratinocytes (HaCaT) and tumor cell lines (SiHa, MCF7, HepG2). Anti-inflammatory activity of the extract was assessed on bacteria-mediated inflammation model using HaCaT cell line.
All anticancer findings to date are in vitro. No animal pharmacological studies or human trials of chervil extracts for cancer have been identified. Not much modern research has been done on the medicinal effects of chervil. However, a report in the journal Pharmaceuticals concludes that chervil holds promise for use in anti-cancer and antimicrobial treatments.
5.4 Enzyme Inhibition (Neurological and Metabolic Relevance)
Evidence level: Preclinical (in vitro molecular docking and enzyme assays)
Anti-enzymatic activity of the methanolic extract was tested on five enzymes associated with therapy of neurodegenerative diseases and diabetes mellitus type 2. The identified compounds demonstrated strong binding to acetylcholinesterase (AChE) and to a lesser extent, to butyrylcholinesterase (BChE), glucosidase, amylase, and modestly to tyrosinase. Molecular docking studies of enzymes and KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway analysis were performed.
These findings suggest possible relevance to Alzheimer's disease (via cholinesterase inhibition) and type 2 diabetes (via glucosidase and amylase inhibition), but they are based solely on molecular binding studies and in vitro assays. No human or animal trials have examined these endpoints for chervil.
5.5 Digestive System
Evidence level: Traditional only — no clinical evidence
The leaves have a mild digestive action and an infusion of fresh leaves can settle the stomach. This represents a traditionally attributed property. No controlled clinical studies in human subjects have examined chervil's effects on gastric function, motility, or digestive symptoms.
5.6 Cardiovascular and Blood Pressure Effects
Evidence level: Traditional only — no clinical evidence
Today, chervil is most widely known as a remedy for high blood pressure. However, of these properties, the most persistently recognized to this day has been the ability to lower blood pressure, but no clinical studies support this or any of the claims.
5.7 Diuretic Effects
Evidence level: Traditional only — no clinical evidence
Herbalists have used chervil throughout history as a diuretic, expectorant, digestive, and skin freshener. No pharmacological studies in humans have verified diuretic activity or quantified urinary output changes attributable to chervil.
6. Body Systems and Health Areas
Based on both traditional use and preclinical research, the following body systems and health domains have been associated with chervil:
- Digestive System: Herbalists have used chervil throughout history as a diuretic, expectorant, digestive, and skin freshener. It is also thought to relieve the symptoms of eczema, gout, kidney stones, and pleurisy.
- Cardiovascular System: Traditional attribution as a hypotensive (blood-pressure-lowering) herb; no clinical evidence exists to support this.
- Urinary System: Traditional diuretic use, associated historically with the treatment of dropsy and kidney stones; unsupported by clinical data.
- Skin and Integument: An infusion of fresh leaves is used as a skin lotion and cleanser, and the juice of its stem and leaves are rubbed on blemishes.
- Ophthalmic (Eyes): In various folk medicines, chervil was used as an eyewash to refresh the eyes.
- Neurological / Cognitive: Preclinical molecular docking evidence suggests binding affinity of chervil phenolics to acetylcholinesterase; traditional use associated with mental clarity and mood elevation.
- Oncology (experimental): In vitro cytotoxic activity against glioblastoma (A172), leukaemia (MOLM-13), and other tumor cell lines; no human evidence.
- Immune / Antimicrobial: In vitro activity against Staphylococcus aureus and Candida species.
- Respiratory System: Traditional expectorant use; no clinical evidence.
7. Dosage Forms and Reported Dosages
There are no established clinical dosages for chervil as a therapeutic agent, as no human clinical trials have been conducted. The following dosage information derives from traditional herbalism references and research methodology sections:
- Herbal infusion (traditional): Fresh herb preparations are described using approximately 2 to 4 tablespoons of fresh herbs with 2 cups of hot water.
- Research extract concentrations (in vitro): Different concentrations of the extract (250–1000 µg/mL) dissolved in DMSO were tested on cell lines in a 48-hour incubation period. These concentrations are relevant only to laboratory cell-culture conditions and cannot be extrapolated to human dosing.
- Total phenolic content (per dry mass): The species contains 1260 mg gallic acid equivalents (GAE) per 100 g dry matter, providing a chemical benchmark for extract standardization in future research.
No pharmacopeial monograph establishing a standardized dose has been identified for chervil (Anthriscus cerefolium) in major authoritative resources including the EMA/HMPC monograph register, German Commission E, or WHO monographs, as of the time of writing.
8. Safety Considerations
8.1 Estragole (Methyl Chavicol) — Genotoxic Carcinogenicity Concern
The most significant safety issue related to chervil as a concentrated herbal preparation is its content of estragole (methyl chavicol), which constitutes the dominant fraction of its essential oil. The essential oil of the herb of Anthriscus cerefolium contains approximately 75% estragole.
The Committee on Herbal Medicinal Products (HMPC) of the European Medicines Agency (EMA) has published a revised Public Statement on the use of herbal medicinal products containing estragole. The guidance values on safety limits are applicable for all medicinal products that contain or may contain estragole. Estragole is a genotoxic carcinogen.
It is recommended that, because of the generally accepted evidence of genotoxic carcinogenicity, exposure to estragole should be kept as low as practically achievable.
The HMPC concluded in 2005 that the present exposure to estragole resulting from consumption of herbal medicinal products (short-term use in adults at recommended posology) does not pose a significant cancer risk. However, exposure to estragole of sensitive groups such as young children, pregnant, and breast-feeding women should be minimized.
It is concluded that the intake of estragole from herbal medicinal products in the general population should be as low as practically achievable because of the generally accepted evidence of genotoxic carcinogenicity. Given several uncertainties, particularly the background human exposure via food, an exact limit cannot be defined until further data on estragole carcinogenicity are available.
It is important to note that the typical dietary exposure to estragole from culinary use of chervil leaves (at normal food quantities) is far lower than from concentrated essential oil preparations. The HMPC's concerns are primarily directed at herbal medicinal products (concentrated extracts, essential oils), not normal food-level consumption.
8.2 Phytophotodermatitis (Contact Phototoxicity)
Chervil has been implicated in "strimmer dermatitis," another name for phytophotodermatitis, due to spray from weed trimmers and similar forms of contact. Other plants in the family Apiaceae can have similar effects.
As a member of Apiaceae, chervil belongs to a plant family strongly associated with phytophotodermatitis. The various plants implicated are diverse and commonly include the Apiaceae, Rutaceae, Moraceae, and other plant families with active photosensitizing ingredients, mainly furocoumarins. When the furocoumarins are exposed to ultraviolet A (UVA) light, skin reactions of erythema, edema, and bullae with subsequent hyperpigmentation can develop.
Two types of toxic reactions occur: one is oxygen-independent, in which the ultraviolet-activated furocoumarins bind to RNA and nuclear DNA; another is oxygen-dependent, where induced furocoumarins cause cell membrane damage and edema. These reactions ultimately lead to cell death (sunburned cells and apoptotic keratinocytes).
8.3 General Safety Profile for Culinary Use
At culinary amounts, chervil is widely regarded as a safe food herb. From a scientific point of view, the plant has hardly been studied. The PubMed database contains fewer than ten studies on the health effects of Anthriscus cerefolium. No documented cases of systemic toxicity from normal dietary consumption of chervil leaves have been identified in the reviewed literature.
8.4 Misidentification Risk
A significant real-world safety concern is the risk of confusing garden chervil (Anthriscus cerefolium) with toxic plants bearing similar appearance, including poison hemlock (Conium maculatum) and fool's parsley (Aethusa cynapium), both also members of the Apiaceae family. This risk is primarily relevant for foragers harvesting wild plants and does not apply to cultivated, commercially sold chervil.
8.5 Absence of Drug Interaction Data
No peer-reviewed pharmacokinetic interaction studies between chervil preparations and pharmaceutical drugs have been identified. Given the traditional attribution of diuretic and hypotensive properties, theoretical interactions with antihypertensive or diuretic medications may merit caution in medicinal doses, but no documented clinical interaction data exist.
9. Current State of Research and Evidence Gaps
Anthriscus cerefolium is a plant traditionally used around the globe since antiquity. Although widely used in many traditional medicines in different cultures, from the scientific point of view it is poorly investigated.
The existing studies do not include clinical studies, meta-analyses, or systematic reviews, but mainly in vitro studies. These are general basic studies — not carried out on humans, but on cell lines in a test tube. Antioxidative, antimicrobial, and anticarcinogenic properties seem to have been best studied.
Major evidence gaps include:
- No randomized controlled trials in humans for any therapeutic indication.
- No in vivo (animal) pharmacological studies specifically on A. cerefolium extracts for most claimed properties.
- No standardized dosage, bioavailability data, or pharmacokinetic studies in humans.
- No systematic characterization of the full coumarin profile of A. cerefolium versus its relative A. sylvestris.
- No formal toxicological assessment of chervil preparations outside of the estragole safety evaluation.
References
Go back